查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433632

3D 細胞培養市場規模、佔有率、趨勢分析報告：按技術、應用、最終用途、地區和細分市場預測，2024-2030 年

3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

3D 細胞培養市場成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，到2030年，全球3D細胞培養市場規模預計將達到32.1億美元，2024年至2030年複合年成長率預計將達到11.22%。

該市場是由體外測試模型的技術進步、對個人化醫療的日益關注以及政府對研發的支援法律所推動的。此外，慢性病盛行率的不斷上升以及細胞療法在治療中的重要性日益增加，正在為產業擴張創造動力。

組織工程在創建 3D 培養模型方面取得了重大進展，該模型比傳統的 2D 細胞培養更準確地模擬體內培養基。因此，3D 細胞培養系統在毒性測試、藥物發現和再生醫學開發中的使用增加。此外，行業參與者最近推出的產品也顯著促進了市場成長。例如，2023 年 6 月，Pixelgen Technologies 推出了首款分子像素化套件，用於細胞表面蛋白質的 3D 空間研究。

此外，微流體、生物列印和高內涵篩檢系統等先進技術的發展正在利用這些模型的功能。這些技術可以更好地控制培養條件、細胞組織以及執行高效篩檢的能力，從而促進了 3D 培養系統的使用。此外，市場相關人員之間加強合作，利用生物列印和微流體技術來開發培養模型，正在推動市場成長。例如，AIM Biotech和MatTek於2023年6月合作，提供創新的idenTX和organiX微流體3D組織培養平台，作為神經生物學、免疫腫瘤學和血管生物學特定領域的完整藥物發現研究服務。

3D培養可以忠實地再現器官的典型微觀結​​構和型態，因此不斷用於需要體內模型來分析藥物對身體組織和器官影響的研究，並且正在開發中。這一因素，再加上各種體外應用的支架材料和結構方面的多種選擇，預計將推動支架收益。最近的研究探討了各種支架的使用，包括石墨烯支架、奈米纖維、天然海洋膠原蛋白和冷凍鑄造。此外，諸如實驗室晶片等技術在多種類型分析中的新興應用，如增殖、刺激、活力、運輸、高內涵篩檢、膜片鉗、代謝活性等，正在推動對先進、高效的解決方案，預計將導致

然而，3D 細胞模型產品缺乏一致性是預期阻礙市場成長的主要缺點之一。此外，細胞培養差異、標準化挑戰、規模和製造問題以及品管問題等各種因素可能會阻礙市場成長。

3D 細胞培養市場報告亮點

  • 2023年，基於支架的技術領域以48.94%的收益佔有率主導市場，這歸因於基於支架的培養在組織工程和再生醫學應用中的應用不斷增加。
  • 2023年，幹細胞研究和組織工程佔最大。另一方面，由於癌症盛行率的上升以及 3D 細胞培養在癌症研究中提供的優勢，預計癌症研究領域將出現最快的成長。
  • 在最終用途領域，生物技術和製藥公司按 2023 年收益佔有率佔據市場主導地位。收益的高成長歸因於生物製藥的持續成長和商業性成功以及大型製藥公司投資組合的擴張。
  • 北美地區在2023年以38.97%的收益佔有率主導全球市場。這是由於先進的醫療基礎設施、新興經濟體、主要參與者以及它們採取的各種策略性舉措的存在。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章技術商業分析

  • 3D細胞培養市場：技術變化分析
  • 鷹架底座
  • 無鷹架
  • 反應器
  • 微流體
  • 生物列印

第 5 章應用程式的商業分析

  • 3D細胞培養市場：應用變化分析
  • 癌症研究
  • 幹細胞研究/組織工程
  • 藥物開發/毒性測試
  • 其他

第 6 章最終用途業務分析

  • 3D 細胞培養市場：最終用途變異分析
  • 生技/製藥公司
  • 學術/研究機構
  • 醫院
  • 其他

第7章 區域業務分析

  • 3D 細胞培養佔有率：按地區分類，2023 年和 2030 年
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/名單
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • PromoCell GmbH
    • Lonza
    • Corning Incorporated
    • Avantor, Inc.
    • Tecan Trading AG
    • REPROCELL Inc.
    • CN Bio Innovations Ltd.
    • Lena Biosciences
Product Code: GVR-1-68038-091-0

3D Cell Culture Market Growth & Trends:

The global 3D cell culture market size is anticipated to reach USD 3.21 billion by 2030 and is anticipated to expand at a CAGR of 11.22% during 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in June 2023, Pixelgen Technologies launched its first molecular pixelation kit for 3D spatial study of proteins present on cell surface.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2023, AIM Biotech and MatTek partnered together to offer innovative idenTX and organiX microfluidic 3D tissue culture platforms along with complete drug discovery research services in specific areas of neurobiology, immune-oncology, and vascular biology.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds. Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

However, the lack of consistency in 3D cell model products is one of the major drawbacks that is expected to hinder the growth of the market. Moreover, various factors such as variability in cell culture, standardized challenges, scale & manufacturing issues, and quality control issues might hamper the market growth.

3D Cell Culture Market Report Highlights:

  • The scaffold-based technology segment dominated the market in 2023 with a revenue share of 48.94% and is attributed to the increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications
  • Stem cell research & tissue engineering held the largest share in 2023, whereas the cancer institute segment is expected to witness the fastest growth owing to the rising prevalence of cancer, and the benefits offered by 3D cell cultures in cancer research
  • In the end-use segment, biotechnology and pharmaceutical companies dominated the market with a revenue share in 2023. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies
  • North America region dominated the global market in 2023 with a revenue share of 38.97%, owing to the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Technology Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis:
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for organ transplantation & tissue engineering
      • 3.2.1.2. Technological advancements in scaffold free technology
      • 3.2.1.3. Rise in investments and R&D funding for cell-based research
      • 3.2.1.4. Increasing focus on developing alternative to animal testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with implementation
      • 3.2.2.2. Lack of compatibility and consistency
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. 3D Cell Culture Market: Technology Movement Analysis
  • 4.2. Scaffold Based
    • 4.2.1. Scaffold based market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Hydrogels
      • 4.2.2.1. Hydrogels market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Polymeric Scaffolds
      • 4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Micropatterned Surface Microplates
      • 4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Nanofiber Based Scaffolds
      • 4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3. Scaffold Free
    • 4.3.1. Scaffold free market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Hanging Drop Microplates
      • 4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Spheroid Microplates with ULA coating
      • 4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Magnetic Levitation
      • 4.3.4.1. Magnetic levitation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Bioreactors
    • 4.4.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Microfluidics
    • 4.5.1. Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Bioprinting
    • 4.6.1. Bioprinting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. 3D Cell Culture Market: Application Movement Analysis
  • 5.2. Cancer Research
    • 5.2.1. Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3. Stem Cell Research & Tissue Engineering
    • 5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Drug Development & Toxicity Testing
    • 5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis

  • 6.1. 3D Cell Culture Market: End-Use Movement Analysis
  • 6.2. Biotechnology & Pharmaceutical Companies
    • 6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. 3D Cell Culture Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Target Disease Prevalence
      • 7.2.2.4. U.S. 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Target Disease Prevalence
      • 7.2.3.4. Canada 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Target Disease Prevalence
      • 7.3.2.4. UK 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Target Disease Prevalence
      • 7.3.3.4. Germany 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Target Disease Prevalence
      • 7.3.4.4. France 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Target Disease Prevalence
      • 7.3.5.4. Italy 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Target Disease Prevalence
      • 7.3.6.4. Spain 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Target Disease Prevalence
      • 7.3.7.4. Denmark 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Target Disease Prevalence
      • 7.3.8.4. Sweden 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Target Disease Prevalence
      • 7.3.9.4. Norway 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Target Disease Prevalence
      • 7.4.2.4. Japan 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Target Disease Prevalence
      • 7.4.3.4. China 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Target Disease Prevalence
      • 7.4.4.4. India 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Target Disease Prevalence
      • 7.4.5.4. Australia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Target Disease Prevalence
      • 7.4.6.4. Thailand 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Target Disease Prevalence
      • 7.4.7.4. South Korea 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Target Disease Prevalence
      • 7.5.2.4. Brazil 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Target Disease Prevalence
      • 7.5.3.4. Mexico 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Target Disease Prevalence
      • 7.5.4.4. Argentina 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Target Disease Prevalence
      • 7.6.2.4. South Africa 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Target Disease Prevalence
      • 7.6.3.4. Saudi Arabia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Target Disease Prevalence
      • 7.6.4.4. UAE 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Target Disease Prevalence
      • 7.6.5.4. Kuwait 3D Cell Culture, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PromoCell GmbH
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Corning Incorporated
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Avantor, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Tecan Trading AG
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. REPROCELL Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. CN Bio Innovations Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Lena Biosciences
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global 3D cell culture market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 Canada 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 16 Europe 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 19 Germany 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 UK 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 22 UK 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 France 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 25 France 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Italy 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 28 Italy 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Spain 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 31 Spain 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Denmark 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 34 Denmark 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 37 Sweden 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Norway 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 40 Norway 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 China 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 47 China 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Japan 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 50 Japan 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 India 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 53 India 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 South Korea 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Korea 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Australia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 59 Australia 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 62 Thailand 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 64 Latin America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 66 Latin America 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Mexico 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 72 Mexico 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Argentina 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 75 Argentina 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 MEA 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 77 MEA 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 79 MEA 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 South Africa 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Africa 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 UAE 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 88 UAE 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 91 Kuwait 3D cell culture market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 3D cell culture market: market outlook
  • Fig. 9 Parent market outlook
  • Fig. 10 3D cell culture market driver impact
  • Fig. 11 3D cell culture market restraint impact
  • Fig. 12 3D cell culture market: technology outlook and key takeaways
  • Fig. 13 3D cell culture market: technology movement analysis
  • Fig. 14 Scaffold based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Scaffold free market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Hanging drop microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 3D cell culture market: application outlook and key takeaways
  • Fig. 27 3D cell culture market: application movement analysis
  • Fig. 28 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 3D cell culture market: end-use outlook and key takeaways
  • Fig. 33 3D cell culture market: end-use movement analysis
  • Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 North America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Norway 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 China 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Japan 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Australia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)